In the latest trading session, 0.87 million Ocular Therapeutix Inc (NASDAQ:OCUL) shares changed hands as the company’s beta touched 1.27. With the company’s most recent per share price at $5.50 changed hands at -$0.25 or -4.35% at last look, the market valuation stands at $851.83M. OCUL’s current price is a discount, trading about -105.64% off its 52-week high of $11.31. The share price had its 52-week low at $2.00, which suggests the last value was 63.64% up since then. When we look at Ocular Therapeutix Inc’s average trading volume, we note the 3-month average coming to 2.45 million.
Ocular Therapeutix Inc (NASDAQ:OCUL) trade information
Instantly OCUL was in red as seen in intraday trades today. With action 10.43%, the performance over the past five days has been green. The drop to weekly highs of 6.08 subtracted -4.35% to the stock’s daily price. The company’s shares are showing year-to-date upside of 23.31%, with the 5-day performance at 10.43% in the green. However, in the 30-day time frame, Ocular Therapeutix Inc (NASDAQ:OCUL) is -12.29% down.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ocular Therapeutix Inc (OCUL) estimates and forecasts
Data shows that the Ocular Therapeutix Inc share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 45.11% over the past 6 months, a -11.76% in annual growth rate that is considerably lower than the industry average of 13.90%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 8.38%. The 2024 estimates are for Ocular Therapeutix Inc earnings to decrease by -13.99%.
OCUL Dividends
Ocular Therapeutix Inc is expected to release its next quarterly earnings report in July.
